Morepen Laboratories Limited has informed the Exchange about Incorporation of a Wholly Owned Subsidiary in Dubai, United Arab Emirates.
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories has incorporated a wholly owned subsidiary named 'MOREPEN LABS - FZCO' in the Free Zone, Dubai, UAE on 18 June 2025. The new entity has an authorised capital of AED 50,000, divided into 5,000 ordinary shares of AED 10 each, fully funded in cash. It will focus on trading in pharmaceuticals and medicines outside the UAE. The promoter and promoter group have no direct interest in the new entity, and no government or regulatory approvals were required for the setup.
This is a small, low-cost international expansion step aimed at building a trading foothold for Morepen's pharmaceutical products in overseas markets. While it signals management's intent to grow globally, the capital involved is minimal and the subsidiary has no existing turnover, so there is little immediate impact on financials or stock price.